direclidine

Search documents
 Neurocrine(NBIX) - 2025 Q3 - Earnings Call Presentation
 2025-10-28 20:30
Advancing Life-Changing Discoveries in Neuroscience Neurocrine Biosciences (Nasdaq: NBIX) Q3 2025 Earnings Presentation October 28 , 2025 Safe Harbor and Forward-Looking Statements In addition to historical facts, this presentation contains forward-looking statements that involve a number of risks and uncertainties. These statements include, but are not limited to, statements related to: the benefits to be derived from our products and product candidates; the value our products and/or our product candidates ...
